WAMU 88.5 : Metro Connection

Filed Under:

D.C. Gigs: For Whom The Bell Tolls

Play associated audio
Perched 160 feet up in the National Cathedral tower, Edward Nassor plays the carillon bells. He says his goal is to always keep the music interesting for both the church audience and residents of the surrounding neighborhoods.
Peter Domingos
Perched 160 feet up in the National Cathedral tower, Edward Nassor plays the carillon bells. He says his goal is to always keep the music interesting for both the church audience and residents of the surrounding neighborhoods.

Perched 160 feet up in the National Cathedral tower, Ed Nassor plays the carillon bells for parishioners worshipping far below. In our latest installment of D.C. Gigs, Nassor talks with Peter Domingos about how he landed this most unusual of jobs and how he tries to play music that's interesting both to his church audience and the surrounding neighborhood.

[Music: "Working for the Weekend" by The Brown Derbies from We Deliver]

NPR

A Personal History Of L.A. Punk: 'It Was A Free-For-All For Outcasts'

John Doe, Exene Cervenka and Dave Alvin of X join Fresh Air to discuss punk's early days. "Anybody could belong to punk that wanted to be there," Cervenka says. "[It] didn't matter how old you were."
NPR

'Touch Tours' Help Blind Experience Philadelphia's Historic Food Scene

A hands-on tour of Philadelphia's historic Italian Market includes time to appreciate the scents and sounds — and opportunities to sample the district's delicious chocolate, cheeses and fresh pastas.
WAMU 88.5

Shaking Up Metro's Board

After another smoke incident and ongoing single tracking delays for fixes, U.S. Secretary of Transportation Anthony Foxx replaced three Metro board members with safety experts, while a Maryland Congressman introduced legislation which would require the next three federally appointed Metro board members have relevant expertise.

NPR

Biotech's Theranos Offers A Cautionary Tale For Silicon Valley

The blood-testing startup led by Elizabeth Holmes soared on hype and celebrity boosters. Now it's under federal scrutiny. It could show that Silicon Valley's success model doesn't work in biotech.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.